Hari Pujar
Operating Partner @ Flagship Pioneering
Cambridge, United States
Hari Pujar is a Series A investor at Flagship Pioneering in Cambridge focused on Biopharma and Biotechnology. Hari Pujar - Operating Partner @ Flagship Pioneering
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Hari Pujar invests in
Stages Hari Pujar invests in
Countries Hari Pujar invests in
Investment Focus
Industry
- Biopharma 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Mirai Bio
|
Mirai Bio has developed an open platform powered by AI to address the main drawbacks and manufacturing to develop the future of genetic medicine. | $50M / Series A / Sep 26, 2024 |
About Flagship Pioneering
Flagship Pioneering conceives, creates, resources, and grows first-in-category ventures to transform human health and sustainability. The company accelerates Flagship Pioneering’s advances in biology, engineering, medicine, energy, and beyond. The firm harnesses science and entrepreneurialism to envision alternative futures, beginning withseemingly unreasonable propositions and navigating to transformational outcomes through an evolutionary methodology.Flagship Pioneering combines innovative capacity, entrepreneurial leadership, and professional capital management in a single enterprise that systematically produces first-in-category companies.
Flagship Pioneering Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Geoffrey von Maltzahn
General Partner
|
|||
|
Hari Pujar
Operating Partner
|
|||
Thomas de Vlaam
Co-Founder FL86
|
|||
Avak Kahvejian
General Partner
|
|||
Bill Johnson
Vice President of Finance
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Hari Pujar invest in?
Hari Pujar invests primarily in Biopharma, Biotechnology and Pharmaceutical startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Hari Pujar last invest?
The most recent investment recorded for Hari Pujar closed in Sep 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
